Welcome to LookChem.com Sign In|Join Free
  • or
Descarboxyl Levofloxacin, also known as L360000, is a degradation product of Levofloxacin. It is an off-white to pale yellow solid with unique chemical properties that make it suitable for various applications across different industries.

178964-53-9

Post Buying Request

178964-53-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

178964-53-9 Usage

Uses

Used in Pharmaceutical Industry:
Descarboxyl Levofloxacin is used as an active pharmaceutical ingredient (API) for the development of new drugs. Its chemical properties and degradation product status from Levofloxacin make it a valuable compound for research and development in the pharmaceutical sector.
Used in Research and Development:
Descarboxyl Levofloxacin serves as a crucial compound in the research and development of new drug formulations and therapies. Its unique chemical properties allow scientists to study its interactions with other compounds and biopolymers, potentially leading to the discovery of novel treatments and applications.
Used in Quality Control and Analysis:
In the pharmaceutical industry, Descarboxyl Levofloxacin is used as a reference material for quality control and analysis. Its distinct chemical properties make it an ideal candidate for testing and validating the purity, potency, and stability of Levofloxacin and its related products.
Used in Environmental Applications:
Descarboxyl Levofloxacin can be utilized in environmental applications, such as the study of drug degradation and its impact on the environment. Understanding the behavior of Descarboxyl Levofloxacin in various environmental conditions can help in developing strategies to minimize the environmental impact of pharmaceutical waste.
Used in Chemical Synthesis:
As a degradation product of Levofloxacin, Descarboxyl Levofloxacin can be used as a starting material for the synthesis of new chemical compounds. Its unique chemical properties make it a valuable building block for the development of novel molecules with potential applications in various industries, including pharmaceuticals, materials science, and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 178964-53-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,9,6 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 178964-53:
(8*1)+(7*7)+(6*8)+(5*9)+(4*6)+(3*4)+(2*5)+(1*3)=199
199 % 10 = 9
So 178964-53-9 is a valid CAS Registry Number.

178964-53-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name Descarboxyl Levofloxacin

1.2 Other means of identification

Product number -
Other names 178964-53-9

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:178964-53-9 SDS

178964-53-9Upstream product

178964-53-9Downstream Products

178964-53-9Relevant academic research and scientific papers

Facile synthesis of carbon quantum dots loaded with mesoporous g-C3N4 for synergistic absorption and visible light photodegradation of fluoroquinolone antibiotics

Wang, Yingfei,Wang, Fengliang,Feng, Yiping,Xie, Zhijie,Zhang, Qianxin,Jin, Xiaoyu,Liu, Haijin,Liu, Yang,Lv, Wenying,Liu, Guoguang

supporting information, p. 1284 - 1293 (2018/02/07)

The development of facile and efficient synthetic approaches of carbon quantum dots loaded with mesoporous g-C3N4 (mpg-C3N4/CQDs) is of critical urgency. Here, a facile strategy was developed to synthesize the mpg-C3N4/CQDs by using calcinations of the mixture of CQDs, cyanamide, and silica colloid. The obtained composite still retained a considerable total surface area, which could offer a larger population of adsorption sites; therefore enhance the capacity for the adsorption of fluoroquinolones antibiotics (FQs). Under visible light irradiation, mpg-C3N4/CQDs demonstrated a higher photocatalytic activity for FQs degradation than did bulk g-C3N4 or mpg-C3N4. This enhancement might have been ascribed to the high surface area of the mpg-C3N4, unique up-converted photoluminescence (PL) properties, and the efficient charge separation of the CQDs. The eradication of FQs followed the Langmuir-Hinshelwood (L-H) kinetic degradation model and absorption pseudo-second-order kinetic model, indicating that surface reactions and chemical sorption played significant roles during the photocatalysis process. The results of electron spin resonance (ESR) technology and reactive species (RSs) scavenging experiments revealed that the superoxide anion radical (O2-) and photo-hole (h+) were the primarily active species that initiated the degradation of FQs. Based on the identification of intermediates and the prediction of reactive sites, the degradation pathways of ofloxacin (OFX) were proposed. A residual antibiotic activity experiment revealed that mpg-C3N4/CQDs provided very desirable performance for the reduction of antibiotic activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 178964-53-9